Align Technology, Inc. (ALGN): a likely value trap?
Avoid — Invisalign demand growth has stalled for years with earnings now shrinking, and cheap valuation reflects a genuinely slower, more competitive business, not a market overreaction.
Down 80% from its all-time high of $725.24 — now $145.35
Why ALGN dropped
Align Technology's stock never recovered from its 2021 peak because the pandemic-era boom in clear aligners (driven by stuck-at-home teens/adults and easy credit) normalized, and growth has settled into low-single digits (4.3% revenue growth here) with earnings now declining (-12.1%) amid rising competition, softer discretionary spending on elective dental work, and uneven international (especially China) demand — not a one-time event but a multi-year structural deceleration.
How this scored 64/100
Bar length shows how much each metric is worth — a 10-point metric is twice as wide as a 5-point one. Hover any row for what it means.
🔒 Read the full AI analysis
Create a free account to unlock the bull case and the risks for ALGN — plus today's other picks.
Analysis generated by SmartStonks's AI from public fundamentals and news, first flagged 2026-10-01. Research only — not financial advice.